Wooly Mammoth startup Colossal seeking at least $20B valuation
De-extinction firm Colossal Biosciences is reportedly targeting a valuation between $20 billion and $30 billion in a new funding round.
The obvious questions
What is the valuation range being sought by Colossal Biosciences?
The company is reportedly seeking a valuation between $20 billion and $30 billion.
What is the primary focus of Colossal Biosciences?
The startup is known for its de-extinction initiatives, specifically work involving the wooly mammoth.
Has the funding round been officially confirmed?
Coverage identifies the funding as currently under discussion and reports the figures as targeted goals.
The story so far
Colossal Biosciences, a company focused on de-extinction efforts including the wooly mammoth, is engaged in discussions to raise new capital. Reports indicate the startup is seeking a valuation of at least $20 billion, with some estimates reaching $30 billion.
Coverage from Axios, TechCrunch, Seeking Alpha, Zamin.uz, and Межа highlights these valuation targets. The outlets report on the status of these funding discussions as the company continues its operations in the biotechnology sector.
Future reports will track whether the funding round reaches the projected $20 billion to $30 billion range. Coverage does not yet specify the timeline for finalizing the deal or the identities of potential investors.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 47d ago.
Sources (5)
- Colossal Biosciences seeks 20 to 30 billion valuation in new funding round Межа. Новини України. · 47d ago
- Colossal Biosciences, the de-extinction startup, could reach a $30 billion valuation Zamin.uz · 47d ago
- Colossal Biosciences discussing new funding at $20B or more valuation: report (IBB:NASDAQ) Seeking Alpha · 47d ago
- Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation TechCrunch · 47d ago
- Wooly Mammoth startup Colossal seeking at least $20B valuation Axios · 47d ago
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Topics
Related trends
Scientists Can Now Spot Alzheimer’s 10 Years Before Symptoms
Diagnostic advancements in blood-based testing are shifting the Alzheimer's detection timeline, enabling the identification of risks years before symptoms.
Scientists find compound that may help muscles stay strong as we age
Researchers have identified a novel molecule that shows potential in reversing or slowing age-related muscle decline.
Breathalyser can tell if you are burning fat from a single exhalation
New sensor technology allows users to detect when their body shifts into fat-burning mode through a single exhalation.
Engineered enzyme erases a stubborn mark of aging by up to 70% in human tissue samples
Researchers have engineered an enzyme capable of reversing a chemical marker of aging in human tissue samples by as much as 70%.
Europe Cancels Venice Biennale Funding Over Russia’s Return
The European Union has withdrawn funding for the Venice Biennale following the reopening of the Russian Pavilion for the first time since 2022.
MIT Scientists Grew Artificial Blood Vessels In The Lab Using Magnets
MIT engineers have developed a method using magnetic fields and mechanical stretching to cultivate artificial blood vessels in laboratory settings.